COMMUNIQUÉS West-GlobeNewswire

Sientra, Inc. Closes $115 Million Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
07/06/2019
SANTA BARBARA, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the closing of its previously announced underwritten [...]
N.M. Cannabis Patient Enrollment on Track to Exceed 80,000 by Year End
07/06/2019
NMDOH adds six conditions to the program, accelerating the need for more plants statewide ALBUQUERQUE, N.M., June 07, 2019 (GLOBE NEWSWIRE) -- The New Mexico Department of Health (NMDOH) added six new qualifying [...]
Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer
07/06/2019
PARIS and CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for age-related diseases, [...]
Surface Oncology to Participate in 40th Annual Goldman Sachs Global Healthcare Conference
07/06/2019
CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced [...]
Helius Medical Technologies to Present at the JMP Securities Life Sciences Conference
07/06/2019
NEWTOWN, Pa., June 07, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that [...]
Rafarma Announces Acquisition of Aeroponic Technology Expecting to Quadruple Production
07/06/2019
Ljubljana, Slovenia, June 07, 2019 (GLOBE NEWSWIRE) -- Rafarma (OTC: RAFA), a Wyoming Corporation, is pleased to announce that it has entered into a technology acquisition agreement with Dr. Yury Martirosian of Russian [...]
Orbis Canada’s Plane Pull Events Raise Money to Fight Avoidable Blindness
07/06/2019
FedEx to host events in Toronto, Calgary and Vancouver Toronto, June 07, 2019 (GLOBE NEWSWIRE) -- This spring, Orbis Canada, the international non-profit working to fight avoidable blindness globally, will be hosting [...]
REPEAT – Over 35,000 Canadians from coast to coast rally to find a cure for type 1 diabetes
07/06/2019
The Sun Life Walk to Cure Diabetes for JDRF aims to raise $5 million to accelerate the pace of research TORONTO, June 07, 2019 (GLOBE NEWSWIRE) -- On Sunday June 9, the Sun Life Walk to Cure Diabetes for JDRF brings [...]
REPEAT – NHL player Max Domi walks with thousands of Montrealers to find a cure for type 1 diabetes
07/06/2019
The Sun Life Walk to Cure Diabetes for JDRF aims to raise $5 million to accelerate the pace of research and raise awareness for type 1 diabetes MONTREAL, June 07, 2019 (GLOBE NEWSWIRE) -- On June 9, 2019, Montreal [...]
RAPPEL – Max Domi, joueur de la LNH, marchera avec des milliers de résidents du Grand Montréal pour trouver une guérison au diabète de type 1
07/06/2019
La Marche pour la guérison du diabète Sun Life FRDJ vise à amasser 5 millions $ pour accélérer le rythme de la recherche et sensibiliser au diabète de type 1 MONTRÉAL, 07 juin 2019 (GLOBE NEWSWIRE) -- Le 9 juin 2019, [...]
Generex Provides Update to Pending 1:1 Stock Dividend
07/06/2019
MIRAMAR, Fla., June 07, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ), in response to the large volume of investor calls, [...]
ALK obtains European approval for its tree SLIT-tablet against allergic rhinitis
07/06/2019
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced that it has successfully completed the marketing authorisation procedure for its tree sublingual allergy immunotherapy (SLIT) tablet in 17 European countries. [...]
Resverlogix Announces Closing of $15 Million Offering
07/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 07, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) is [...]
Better Choice Company Announces Pet CBD Research & Development Partnership in Israel with CannaSoul
07/06/2019
NEW YORK, June 07, 2019 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (OTCQB: BTTR) (the “Company”), an animal health and wellness CBD company, today announced that it has entered into a research and development [...]
TYME Announces Abstract Selected for Presentation at the European Society for Medical Oncology 21st World Congress on Gastrointestinal Cancer 2019
07/06/2019
SM-88 (racemetyrosine) is an oral, investigational cancer metabolism-based therapy that has demonstrated responses across 15 different cancers New oral approach aimed at disrupting cancer metabolism in metastatic [...]
AzurRx BioPharma Announces Notice of Allowance of U.S. and Japan Patents Covering a MTAN Inhibitor for Treating H. Pylori Infections, the Primary Cause of Stomach Ulcers
07/06/2019
BROOKLYN, N.Y., June 07, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), today announced that both the United States Patent and Trademark Office and the Japan Patent Office [...]
GBT Announces New Employment Inducement Grants
07/06/2019
SOUTH SAN FRANCISCO, Calif., June 07, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on June 1, 2019, the compensation committee of GBT’s board of directors granted 19 [...]
Applied Therapeutics to Present Data Highlighting AT-001 for the Treatment of Diabetic Cardiomyopathy in Late Breaking Session at the American Diabetes Association 79th Annual Scientific Sessions
07/06/2019
AT-001, a novel, potent and selective aldose reductase inhibitor, is expected to start a pivotal study later this year NEW YORK, June 07, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical- [...]
Amarin to Present Findings Regarding Challenges of Current Treatment Options in Reducing Cardiovascular Risks for Diabetes Patients, Even for Those With Controlled Cholesterol Levels, at Annual American Diabetes Association (ADA) Meeting
07/06/2019
Meeting Coverage of 2019 Updated ADA Standards of Medical Care in Diabetes to Include Role of Icosapent Ethyl as a Management Option for Diabetic Patients with Cardiovascular Risks, Based on Landmark REDUCE-IT TM Trial [...]

Pages